Neuberger Berman Group LLC Amphastar Pharmaceuticals, Inc. Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q2 2024
A detailed history of Neuberger Berman Group LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,622,609 shares of AMPH stock, worth $77.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,622,609
Previous 1,659,817
2.24%
Holding current value
$77.9 Million
Previous $72.9 Million
10.95%
% of portfolio
0.05%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$128 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$93.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$81.2 Million0.07% of portfolio
-
State Street Corp Boston, MA1.53MShares$73.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.35B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...